Drug class
Second-generation, long-acting histamine H1-receptor antagonist; antihistamine
Mechanism of action
Selectively antagonises peripheral histamine H1 receptors, reducing histamine-mediated allergic symptoms. It has limited penetration into the central nervous system and relatively low sedative activity at therapeutic doses.
General use cases
- Symptomatic relief of seasonal and perennial allergic rhinoconjunctivitis, including hay fever.
- Symptomatic treatment of urticaria.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
